Autologous antibodies that bind neuroblastoma cells
Sun Y, Sholler GS, Shukla GS, Pero SC, Carman CL, Zhao P, Krag DN Autologous antibodies that bind neuroblastoma cells, J Immunol Methods. 2015 Jul 23. pii: S0022-1759(15)30025-9. doi: 10.1016/j.jim.2015.07.009. [Epub ahead of print]
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
Saulnier Sholler G, Gerner EW, Bergendahl G, MacArthur RB, Vander Werff A, Ashikaga T, Bond JP, Ferguson W, Roberts W, Wada RK, Eslin D, Kraveka JM, Kaplan J, Mitchell D,[...]
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
Saulnier Sholler GL, Bond JP, Bergendahl G, Dutta A, Dragon J, Neville K, Ferguson W, Roberts W, Eslin D, Kraveka J, Kaplan J, Mitchell D, Parikh N, Merchant M, Ashikaga[...]
YM155 Inhibits Neuroblastoma Cell Migration and Survival in Vitro and Tumor Growth and Metastatic Burden in a Pre-Clinical Model
Calderone HM., Dutta A, Smith L, Eckardt A, Zhao P, Saulnier Sholler GL, YM155 Inhibits Neuroblastoma Cell Migration and Survival in Vitro and Tumor Growth and Metastatic Burden in a Pre-Clinical[...]
Sustained Clinical Response to Treatment Directed by Genomic Expression Profiling Suggests mTOR Signaling is an Effective Target in Choroid Plexus Carcinoma
Cornelius A, Foley J, Mitchell D, Nagulapally A, Bond J, Huntelman M, Corneveaux J, Trent J, Saulnier Sholler G. Sustained Clinical Response to Treatment Directed by Genomic Expression Profiling Suggests mTOR[...]
Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma
Lozier AM, Rich ME, Grawe AP, Peck AS, Zhao P, Ting-Tung Chang, Bond JP, Saulnier Sholler G, Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma. Oncotarget 6(1):[...]
A Feasibility Trial using Molecular-Guided Therapy for the Treatment of Patients with Refractory or Recurrent Neuroblastoma
Saulnier Sholler G, Bergendahl G, Vander Werff A, Ferguson W, Roberts W, Eslin D, Kraveka J, Kaplan J, Mitchell D, Parikh N, Neville K, Ashikaga T, Bond J, Hanna G,[...]
PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis and is synergistic with bortezomib in neuroblastoma
Saulnier Sholler G, Currier E, Dutta A, Slavik M, Illenye S, Mendonca MC, Dragon J, Roberts S, Bond JP, PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis[...]
Nifurtimox and radiation combination increases reactive oxygen species and induces apoptosis in medulloblastoma cells
Saulnier Sholler G, Eslin D. Nifurtimox and radiation combination increases reactive oxygen species and induces apoptosis in medulloblastoma cells. American Association for Cancer Research Pediatric Cancer at the Crossroads: Translating Discovery into[...]
DFMO treatment affects the LIN28/Let-7 axis resulting in reduced glycolytic metabolism in Neuroblastoma
Kendzicky A, Rich M, Peck A, Zhao P, VanSickle E, McClung H, Chang A, Saulner Sholler G. DFMO treatment affects the LIN28/Let-7 axis resulting in reduced glycolytic metabolism in Neuroblastoma. American[...]